KEYNOTE: From Evidence to Action: Thinking Beyond the Clinical Setting
Dr. Samantha Nutt, Physician, Global Humanitarian, Founder of War Child, Bestselling Author
You conducted the trial. You have the evidence. Where can you go from here? In this keynote address, Dr. Samantha Nutt will expand our horizons and motivate action by drawing on her own experience as a physician and researcher turned global humanitarian. Early in her career, Samantha’s research and medical practice fueled her desire to tackle global health challenges. Today, she is the founder of War Child, a global humanitarian organization that promotes education, health and opportunities for children in communities affected by war. An award-winning storyteller, Samantha will discuss how research, evidence and collaboration are essential to tackling the most pressing health issues of our time and share how we can move that evidence forward to improve the lives of those who need it most.
Communicating Evidence: How to Get Your Science Heard
The clinical trials community plays a vital role in generating evidence, but are we doing enough to communicate it? As a credible voice in a world of fake news and misinformation, how can you make sure the new evidence you discover reaches the target audience? This panel of experts will discuss best practices for communicating evidence, public perceptions and engaging citizen scientists, and the value that it can bring to your career.
- Dr. Samantha Nutt, Physician, Global Humanitarian, Founder of War Child, Bestselling Author (Moderator)
- Hannah Hoag, Deputy Editor, The Conversation Canada
- Dr. Samantha Yammine, “Science Sam”, Neuroscientist, Science Communicator, and Digital Media Producer
- Dr. Ryan Wiley, President, Shift Health
- Lili Shalev-Shawn, Chief Communications and Marketing Officer, Women’s College Hospital
- Mike Heinrich, Managing Director, Reframe Health Lab
What do Canadians want and expect? Rethinking privacy and data in 2020
Abigail Carter-Langford, VP, Governance, Risk & Compliance; Chief Privacy Officer, Canada Health Infoway
Candid Perspectives on Participating in Clinical Trials
Have you ever participated in a clinical trial or wondered what it’s like to be on the participant side of a clinical trial? Three clinical trial participants will candidly share their experiences, including: what they liked, what they didn’t like, what surprised them, and anything else they’re comfortable sharing. A moderated discussion with questions from the audience will allow exploration of the experience of being in a clinical trial.
Open Science Drug Discovery: The Path to Affordable Medicines
Dr. Aled Edwards, Director, Structural Genomics Consortium
Moving consent into the new millennium: Experiences from The Rethinking Clinical Trials (REaCT) Program
Dr. Mark Clemons, Clinical Investigator at the Ottawa Hospital Research Institute (Cancer Therapeutics Program); Staff Medical Oncologist (The Ottawa Hospital); Professor of Medicine (University of Ottawa)
Regulatory Updates from Health Canada
David K. Lee, Chief Regulatory Officer, Health Canada
As the science advances, how are Canadian regulatory policies keeping up? In this session, David K. Lee, Chief Regulatory Officer for the Health Products and Food Branch, will discuss recent Health Canada initiatives that aim to update the regulation of clinical trials and facilitate innovation in advanced therapeutic products while ensuring the highest quality ethical and quality standards.
Faster, further together: Lessons in starting clinical trials more quickly
As the global clinical research environment becomes more competitive, Ontario faces increasing pressure to ensure research costs, start-up timelines and recruitment rates are where they need to be to continue attracting investment. Innovations including the QuickSTART program are helping industry and institutions work more colloaboratively to improve budgeting, processes and start-up timelines. In this session, panelists will discuss what’s working well and what strategies we can implement to go further, faster together.
- Paul MacPherson, Director of Research, UHN
- George Memari, Cllinical Trials Operations, Novartis Pharmaceuticals Canada Inc.
- Claire McCann, Medical Director, Odette Cancer Centre Clinical Research, Trials Program, Sunnybrook Health Sciences Centre
- Cheryl Litchfield, Manager, Grants and Contracts, Lawson Health Research Institute, London Health Sciences Centre
Gene Therapies and Clinical Trials